CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) Stock
7 of the hedge funds AlphaScala tracks reported CLOV in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Renaissance Technologies's at $14.71M. Company insiders reported 0 open-market buys and 18 sales on SEC Form 4 in the 90 days to Oct 21, 2026.
Which hedge funds own CLOV?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Renaissance Technologies Jim Simons (founder) | 2.81M | $14.71M | -17% |
| Citadel Ken Griffin | 2.16M | $11.34M | +15% |
| D.E. Shaw David Shaw | 1.97M | $10.30M | +2060% |
| Marshall Wace | 1.56M | $8.19M | NEW |
| Millennium Management Israel Englander | 1.11M | $5.81M | -5% |
| Point72 Steve Cohen | 1.07M | $5.60M | +113% |
| Blackstone | 64K | $336.7K | NEW |
13F holdings as of Jun 30, 2026
Explore all tracked funds →Are CLOVER HEALTH INVESTMENTS, CORP. /DE insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Oct 20, 26 | Soares Karen | Chief Legal Officer | SELL | 19.3K | $90K |
| Oct 19, 26 | Reynoso Jamie L. | CEO, Medicare Advantage | SELL | 4.1K | $18K |
| Oct 15, 26 | Reynoso Jamie L. | CEO, Medicare Advantage | SELL | 18.3K | $86K |
| Oct 15, 26 | Wai Conrad | CEO, Counterpart Health | SELL | 23.6K | $111K |
| Oct 15, 26 | Thornton Joseph Clay | Interim CFO | SELL | 4.6K | $21K |
| Oct 15, 26 | Soares Karen | Chief Legal Officer | SELL | 14.7K | $69K |
| Oct 15, 26 | Toy Andrew | Chief Executive Officer | SELL | 62.2K | $291K |
| Oct 7, 26 | Reynoso Jamie L. | CEO, Medicare Advantage | SELL | 2.0K | $9K |
| Oct 5, 26 | Reynoso Jamie L. | CEO, Medicare Advantage | SELL | 8.8K | $39K |
| Oct 1, 26 | Toy Andrew | Chief Executive Officer | SELL | 318.8K | $1.3M |
SEC Form 4 filings as of Oct 21, 2026
See cluster-buy signals across all tickers →CLOV price chart
Powered by TradingViewWhat does CLOVER HEALTH INVESTMENTS, CORP. /DE do?
Clover Health Investments, Corp. is a healthcare technology company that provides Medicare Advantage plans in the United States. Its primary focus is empowering physicians to proactively manage chronic diseases among Medicare-eligible individuals through its proprietary software platform, Clover Assistant. This cloud-based tool aggregates patient data from the healthcare ecosystem, delivering personalized insights for early detection, identification, and management of conditions to support clinical decision-making and improve health outcomes. The company operates in the insurance segment, offering preferred provider organization (PPO) and health maintenance organization (HMO) plans, with an emphasis on wide-network, high-choice PPO options available in several states. Clover Health Investments, Corp. integrates technology-driven preventive care into its offerings, positioning it as a key player in value-based healthcare within the Medicare Advantage market. Founded in 2014 and headquartered in Wilmington, Delaware, it serves members seeking enhanced, data-informed medical experiences.